PRF Technologies (PRFX) Cash from Investing Activities (2021 - 2024)
PRF Technologies (PRFX) recorded quarterly Cash from Investing Activities of -$5000.0 in Q2 2024, up 28.57% on a QoQ basis from -$7000.0 in Q1 2024, and up 99.5% year-over-year from -$2506.3 in Q3 2023.
PRF Technologies (PRFX) Cash from Investing Activities (2021 - 2024) Analysis & Trends
PRF Technologies has disclosed Cash from Investing Activities across 4 years of filings, most recently posting -$5000.0 for Q2 2024.
- Quarterly Cash from Investing Activities rose 99.5% year-over-year to -$5000.0 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $979000.0 (up 197.61% YoY) and the FY2025 annual result came in at -$982000.0, down 7453.85% from the prior year.
- Cash from Investing Activities climbed to -$5000.0 in Q2 2024, from -$7000.0 in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $22.0 million in Q4 2021 and troughed at -$22.0 million in Q3 2021.
- A 4-year average of -$6166.7 and a median of -$6000.0 in 2024 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2023 — Cash from Investing Activities surged 3467.86% — and 2024, when it slumped 100.12%.
- Tracing PRFX's Cash from Investing Activities over 4 years: stood at $22.0 million in 2021, then slumped by 99.87% to $28000.0 in 2022, then jumped by 3467.86% to $999000.0 in 2023, then slumped by 100.5% to -$5000.0 in 2024.
- Business Quant data shows PRFX's Cash from Investing Activities at -$5000.0 in Q2 2024, -$7000.0 in Q1 2024, and $999000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 229.00 Mn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | -87.00 Mn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 743.70 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | -506.20 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | -60.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -2.08 Bn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 25.99 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | -15.45 Mn |
| 10 | PRF Technologies | 984,918.95 | -2.41 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -5,000.00 |
| Jun 30, 2024 | -5,000.00 |
| Mar 31, 2024 | -7,000.00 |
| Mar 31, 2024 | -7,000.00 |
| Dec 31, 2023 | 999,000.00 |
| Dec 31, 2023 | 999,000.00 |
| Sep 30, 2023 | -8,000.00 |
| Sep 30, 2023 | -8,000.00 |
| Jun 30, 2023 | -1.00 Mn |
| Jun 30, 2023 | -1.00 Mn |
| Mar 31, 2023 | 6.00 Mn |
| Mar 31, 2023 | 6.00 Mn |
| Dec 31, 2022 | 28,000.00 |
| Dec 31, 2022 | 28,000.00 |
| Sep 30, 2022 | -6.03 Mn |
| Sep 30, 2022 | -6.03 Mn |
| Dec 31, 2021 | 21.95 Mn |
| Dec 31, 2021 | 21.95 Mn |
| Sep 30, 2021 | -21.98 Mn |
| Sep 30, 2021 | -21.98 Mn |